What Happened Today?
Thursday July 9. 2026
MICRO → MACRO?
Micro Technologies upped its committed investment to $250 billion. That gave the tech sector quite a lift. Congress is happy. They must be share holders.
The KOPSI rolled over but did not plummet over night and squeaked out a modest gain. That bodes well for the health of the dip buyers.
Share repurchases were down this past quarter but still chugging along.
It appears that the world has realized that remaining drones can’t really do much damage to a tanker. It’s like a gnat crashing into an elephant and ships are no longer trembling at the prospect of crossing the Strait as predicted.
Or maybe insurers have realized no one is willing to pay the increased rates?
MICRO
Virax ($VRAX) pulled off an impressive RS and run today on a supply agreement. Micron poured some contract. Virax signed some paper work. Both went way up. This chart was obvious. Just missed it.
I exited Faeth Therapeutics ($FTH) for ~80% in the competition account. Second round here. Rode it from ~$10-$30 twice this year.
Will revisit in the future.
I rotated that capital into Tscan Therapeutics ($TCRX) which sold off after a big move yesterday. That “wait” signal is from January. The company recently released data is is about to start a Phase 3.
This is another stock I think might attract retail during the trial period but I don’t expect much for 12-18 months. But, then again I didn’t expect much from Faeth either and that moved quickly.
So who knows?
Typically, retail interest doesn’t begin to show up until midway through a Phase 3. So we’re looking at 2028 maybe. Go back and look at Sellas and aTyr Pharma’s reddit activity.
My interest in this now is that if (when?) Sellas ($SLS) “vaccine” fails people might start looking for AML drugs and find this one. It’s cheap and it too has a lot of warrants that would benefit from a retail interest surge.
TScan’s drug is another variation of CAR-T but going after the HA-2 antigen. And I like to buy as many as I can that don’t seem like outright scams and play the odds.
MDxHealth is getting retail interest as well. I know nothing about it other than it tripped distribution, hit the channel and then tripped consolidation. If there is a 13-G filed it will have completed a box setup. I had never heard of this company until it tripped a scan.
The code is predicting volatility. Need to check the debt levels here. I tend to avoid Yellow stocks but it might be interesting to some people reading.
Enphase just crossed its per-share-cost line. If you are into support this is how you actually should think in terms of support.
No position in this.
Speaking of energy stocks watch Encore Energy as it approaches $1.00. It recently tripped Acc/Consolidation and is also retail heavy.
I am not carrying any options (hedges or otherwise) as of today. Will wait and see how Korea acts.
When the dip buying stops I will be playing the VIX. But, that might be days, weeks, years away. Just remember. When Koreans start throwing tantrums, VIX go up. Famous saying on Dagobah.
I am just happy the VIX is heading back to 13… hopefully.
— AJ